Diagnostic performance and clinical usefulness of CRP and PCT (as well as new biomarkers in development5) are increasingly explored in many tropical fields but in very different epidemiological and clinical scenarios (primary care facilities, hospitals, undifferentiated fever, respiratory tract infection,...). This evidence concerns the gene CRP and Respiratory tract infection.